• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: tafamidis
Date Designated: 05/23/2006
Orphan Designation: Treatment of familial amyloid polyneuropathy
Orphan Designation Status: Designated/Designation Withdrawn or Revoked
Date Designation Withdrawn or Revoked: 11/16/2021
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Pfizer, Inc.
P. O. Box 8299
Philadelphia, Pennsylvania 19101
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.